Anavex Life Sciences
AVXL
#6581
Rank
โ‚ฌ0.43 B
Marketcap
5,09ย โ‚ฌ
Share price
-2.08%
Change (1 day)
-25.04%
Change (1 year)

Anavex Life Sciences (AVXL) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : โ‚ฌ10.6 M

According to Anavex Life Sciences 's latest financial reports the company's total liabilities are โ‚ฌ10.6 M. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Anavex Life Sciences - Total liabilities on balance sheet (from 2005 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-09-30โ‚ฌ11.83 M13.41%
2022-09-30โ‚ฌ10.43 M11.89%
2021-09-30โ‚ฌ9.33 M49.62%
2020-09-30โ‚ฌ6.23 M34.97%
2019-09-30โ‚ฌ4.62 M38.22%
2018-09-30โ‚ฌ3.34 M9.5%
2017-09-30โ‚ฌ3.05 M7.24%
2016-09-30โ‚ฌ2.84 M20.31%
2015-09-30โ‚ฌ2.36 M-58.07%
2014-09-30โ‚ฌ5.64 M167.12%
2013-09-30โ‚ฌ2.11 M-5.95%
2012-09-30โ‚ฌ2.24 M126.6%
2011-09-30โ‚ฌ0.99 M-58.92%
2010-09-30โ‚ฌ2.41 M-17.52%
2009-09-30โ‚ฌ2.92 M83.22%
2008-09-30โ‚ฌ1.59 M388.3%
2007-09-30โ‚ฌ0.32 M1378.26%
2006-09-30โ‚ฌ0.02 M-1.53%
2005-09-30โ‚ฌ0.02 M1005.93%
2004-09-30โ‚ฌ0 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚ฌ82.3 M 675.97%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.85 B 7,965.55%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.10 B 906.57%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ8.86 M-16.39%๐Ÿ‡บ๐Ÿ‡ธ USA